Centene (CNC) Competitors $59.58 -0.13 (-0.22%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CNC vs. ELV, CI, HUM, MOH, UNH, OSCR, TRUP, ALHC, CLOV, and BHGShould you be buying Centene stock or one of its competitors? The main competitors of Centene include Elevance Health (ELV), The Cigna Group (CI), Humana (HUM), Molina Healthcare (MOH), UnitedHealth Group (UNH), Oscar Health (OSCR), Trupanion (TRUP), Alignment Healthcare (ALHC), Clover Health Investments (CLOV), and Bright Health Group (BHG). These companies are all part of the "hospital & medical service plans" industry. Centene vs. Elevance Health The Cigna Group Humana Molina Healthcare UnitedHealth Group Oscar Health Trupanion Alignment Healthcare Clover Health Investments Bright Health Group Centene (NYSE:CNC) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, media sentiment, dividends, institutional ownership, community ranking and earnings. Do analysts recommend CNC or ELV? Centene currently has a consensus target price of $80.92, suggesting a potential upside of 35.82%. Elevance Health has a consensus target price of $539.20, suggesting a potential upside of 47.34%. Given Elevance Health's stronger consensus rating and higher possible upside, analysts plainly believe Elevance Health is more favorable than Centene.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Centene 1 Sell rating(s) 4 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.57Elevance Health 1 Sell rating(s) 2 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.81 Which has more risk and volatility, CNC or ELV? Centene has a beta of 0.46, indicating that its share price is 54% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Does the MarketBeat Community prefer CNC or ELV? Centene received 186 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 73.41% of users gave Centene an outperform vote while only 67.21% of users gave Elevance Health an outperform vote. CompanyUnderperformOutperformCenteneOutperform Votes104973.41% Underperform Votes38026.59% Elevance HealthOutperform Votes86367.21% Underperform Votes42132.79% Do institutionals & insiders have more ownership in CNC or ELV? 93.6% of Centene shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.3% of Centene shares are owned by company insiders. Comparatively, 0.4% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media favor CNC or ELV? In the previous week, Centene had 21 more articles in the media than Elevance Health. MarketBeat recorded 34 mentions for Centene and 13 mentions for Elevance Health. Centene's average media sentiment score of 0.57 beat Elevance Health's score of 0.32 indicating that Centene is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 13 Very Positive mention(s) 2 Positive mention(s) 10 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive Elevance Health 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Is CNC or ELV more profitable? Elevance Health has a net margin of 3.68% compared to Centene's net margin of 1.90%. Elevance Health's return on equity of 19.56% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Centene1.90% 13.32% 4.32% Elevance Health 3.68%19.56%7.22% Which has stronger valuation & earnings, CNC or ELV? Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCentene$161.73B0.19$2.70B$5.7610.34Elevance Health$174.02B0.49$5.99B$27.4313.34 SummaryElevance Health beats Centene on 14 of the 19 factors compared between the two stocks. Ad Porter & CompanyI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Get Centene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNC vs. The Competition Export to ExcelMetricCenteneHospital & medical service plans IndustryMedical SectorNYSE ExchangeMarket Cap$30.08B$59.06B$5.13B$19.18BDividend YieldN/A1.78%4.93%3.60%P/E Ratio10.3419.8789.5841.24Price / Sales0.190.561,115.0117.60Price / Cash6.158.8842.8221.28Price / Book1.234.504.805.32Net Income$2.70B$3.04B$120.04M$989.88M7 Day Performance0.27%-6.51%-1.91%-3.54%1 Month Performance-1.19%-11.85%11.48%-3.68%1 Year Performance-18.85%20.93%30.59%12.14% Centene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNCCentene4.9262 of 5 stars$59.58-0.2%$80.92+35.8%-17.5%$30.08B$161.73B10.3467,700Analyst ForecastInsider TradeHigh Trading VolumeELVElevance Health4.8515 of 5 stars$375.54-1.5%$539.20+43.6%-20.3%$87.10B$171.34B13.90104,900Analyst DowngradeAnalyst RevisionPositive NewsCIThe Cigna Group4.9978 of 5 stars$277.36-1.6%$394.64+42.3%-6.5%$77.15B$229.75B26.1672,500HUMHumana4.6956 of 5 stars$268.19-2.2%$304.15+13.4%-45.3%$32.29B$106.37B24.2867,600Analyst ForecastMOHMolina Healthcare4.8611 of 5 stars$298.59-1.5%$367.17+23.0%-16.2%$17.08B$39.20B15.39123,123Analyst ForecastPositive NewsUNHUnitedHealth Group4.9919 of 5 stars$502.26-3.5%$626.84+24.8%-3.1%$462.22B$389.07B33.61440,000OSCROscar Health2.8632 of 5 stars$13.69+0.2%$21.56+57.5%+74.8%$3.39B$5.86B0.002,400TRUPTrupanion1.2393 of 5 stars$54.45+3.3%$44.67-18.0%+60.5%$2.31B$1.24B-164.781,142ALHCAlignment Healthcare0.6998 of 5 stars$11.33-1.0%$11.44+1.0%+31.6%$2.17B$2.47B-14.871,536CLOVClover Health Investments3.199 of 5 stars$3.21+3.2%$4.00+24.6%+229.6%$1.61B$2.12B-15.55552Analyst ForecastBHGBright Health GroupN/A$5.16+3.0%N/A-24.2%$41.19M$2.76B-0.022,840Gap Down Related Companies and Tools Related Companies ELV Alternatives CI Alternatives HUM Alternatives MOH Alternatives UNH Alternatives OSCR Alternatives TRUP Alternatives ALHC Alternatives CLOV Alternatives BHG Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CNC) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.